{
    "Trade/Device Name(s)": [
        "Prodigy Choice Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Prodigy Diabetes LLC",
    "510(k) Number": "K122340",
    "Predicate Device Reference 510(k) Number(s)": [
        "K073118"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "November 26, 2013",
    "Summary Letter Received Date": "October 21, 2013",
    "Submission Date": "October 21, 2013",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Prodigy Choice Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical method",
        "Dry reagent biosensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Kit",
        "Lancing Device",
        "Lancet",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Prodigy Choice Blood Glucose Monitoring System for quantitative measurement of glucose in capillary whole blood using an electrochemical biosensor.",
    "Indications for Use Summary": "For quantitative measurement of glucose in fresh capillary whole blood from fingertip, forearm, palm, upper-arm, calf, or thigh by a single person for self-testing at home as an aid to monitor diabetes control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}